Assessment of the Efficacy of Medrol Dose Pack for Acute Post-Concussive Headaches
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNorthwell Health
About this trial
This novel pilot project will assess the effectiveness of corticosteroids in treatment of acute post-concussion headache. The investigators hypothesize that the use of corticosteroids will cause significant headache reduction in frequency and/or intensity than individuals who undergo the current standard of care. Additionally, the investigators hypothesize that corticosteroid use will lead to a reduction in other somatic symptoms including vestibular symptoms, leading to quicker return to school, work, and/or ability to play sports.
Eligibility criteria
Qualifiers
Provision of signed and dated informed consent form (in person or via telehealth)
Stated willingness to comply with all study procedures and availability for the duration of the study
Male or female, aged >18 years old
Ability to take oral medication and be willing to adhere to the study regimen as described in this protocol
Disqualifiers
Any evidence of known intracranial hemorrhage on neuroimaging
Headache developing after 7 days post injury and patient presenting after 30 days from initial trauma
Headache occurs < 4 hours per day
Headache does not occur daily
Trial design
Treatments tested in this trial
- Methylprednisolone
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov